Pre‐column Derivatization and Ultra‐High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry‐based Method Development of Gemcitabine in Reversed‐Phase Column for Pharmaceutical Applications

Abstract Gemcitabine (Gem) is a Food and Drug Administration‐approved chemotherapeutic agent used for the treatment of a wide variety of cancers. Yet, its clinical application is constrained by poor pharmacokinetics and early degradation in biological environments, thus creating the need for developing a sensitive, specific, and reliable analytical method to quantify it. The present study illustrates a validated ultra‐high‐performance liquid chromatography‐tandem mass spectrometry (UHPLC–MS/MS) method duly incorporating a new pre‐column derivatization step for enhanced detection and retention. The derivatization was carried out using 9‐fluorenylmethyloxycarbonyl chloride, which selectively reacts with the primary amine group of Gem and forms a stable, non‐toxic, monosubstituted derivative. This method provides higher specificity and stability compared to the earlier reported methods. Indomethacin has been utilized as an internal standard to ensure maintaining analytical continuity for accurate quantitation of Gem. Chromatographic separation was done on an Acquity UPLC BEH C18 reversed‐phase column (2.1 × 100 mm, 1.7 µm particle size) with the help of a linear gradient elution program. The Waters Acquity UPLC‐MS/MS system (XEVO‐TQD, Milford, MA, USA), having a triple quadrupole mass analyzer and operating in multiple reaction monitoring mode with positive electrospray ionization, was utilized for detection purposes with a total run time of 8 min. This method illustrated excellent linearity within the concentration limit of 3.9–2000 ng/mL and correlation coefficient (R 2 ) of 0.9997, which conforms to the ICH Q2(R2) guidelines. It demonstrated high precision and had relative standard deviation values under 2%. The limit of detection and limit of quantification were found to be at 3.9 and 13 ng/mL, respectively. As the present method was found to be simple, fast, and precise with high levels of sensitivity, it proves to be a well‐suited approach for the quantitative analysis of Gem in a variety of pharmaceutical and clinical research applications.

Authors

Institutions

Publication Details

Journal
Separation Science Plus
Published
2025-10-01
DOI
https://doi.org/10.1002/sscp.70139
Primary Topic
Analytical Chemistry and Chromatography
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pre‐column Derivatization and Ultra‐High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry‐based Method Development of Gemcitabine in Reversed‐Phase Column for Pharmaceutical Applications

Asif Husain, Rikeshwer Prasad Dewangan, Lalit Kumar Sharma, Farha Bano
Separation Science Plus
Analytical Chemistry and Chromatography
article

Pre‐column Derivatization and Ultra‐High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry‐based Method Development of Gemcitabine in Reversed‐Phase Column for Pharmaceutical Applications

Asif Husain, Rikeshwer Prasad Dewangan, Lalit Kumar Sharma, Farha Bano
article en

Abstract

Abstract Gemcitabine (Gem) is a Food and Drug Administration‐approved chemotherapeutic agent used for the treatment of a wide variety of cancers. Yet, its clinical application is constrained by poor pharmacokinetics and early degradation in biological environments, thus creating the need for developing a sensitive, specific, and reliable analytical method to quantify it. The present study illustrates a validated ultra‐high‐performance liquid chromatography‐tandem mass spectrometry (UHPLC–MS/MS) method duly incorporating a new pre‐column derivatization step for enhanced detection and retention. The derivatization was carried out using 9‐fluorenylmethyloxycarbonyl chloride, which selectively reacts with the primary amine group of Gem and forms a stable, non‐toxic, monosubstituted derivative. This method provides higher specificity and stability compared to the earlier reported methods. Indomethacin has been utilized as an internal standard to ensure maintaining analytical continuity for accurate quantitation of Gem. Chromatographic separation was done on an Acquity UPLC BEH C18 reversed‐phase column (2.1 × 100 mm, 1.7 µm particle size) with the help of a linear gradient elution program. The Waters Acquity UPLC‐MS/MS system (XEVO‐TQD, Milford, MA, USA), having a triple quadrupole mass analyzer and operating in multiple reaction monitoring mode with positive electrospray ionization, was utilized for detection purposes with a total run time of 8 min. This method illustrated excellent linearity within the concentration limit of 3.9–2000 ng/mL and correlation coefficient (R 2 ) of 0.9997, which conforms to the ICH Q2(R2) guidelines. It demonstrated high precision and had relative standard deviation values under 2%. The limit of detection and limit of quantification were found to be at 3.9 and 13 ng/mL, respectively. As the present method was found to be simple, fast, and precise with high levels of sensitivity, it proves to be a well‐suited approach for the quantitative analysis of Gem in a variety of pharmaceutical and clinical research applications.

Separation Science PlusVol. 8(10)
Jamia Hamdard (IN)
Openalex Percentile: Top 74%
Analytical Chemistry and Chromatography
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.